[HTML][HTML] The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study
…, I Al Sulaihim, B Alanazi, BS Al-Dosari… - Frontiers in Public …, 2022 - frontiersin.org
Background The cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may
be attributed to the hyperinflammatory state leading to increased mortality in patients with …
be attributed to the hyperinflammatory state leading to increased mortality in patients with …
[HTML][HTML] Ketamine-based sedation use in mechanically ventilated critically ill patients with COVID-19: A multicenter cohort study
…, BS Al-Dosari, AA Alenazi, S Alsohimi… - Saudi Pharmaceutical …, 2024 - ncbi.nlm.nih.gov
Methods Adult critically ill patients with COVID-19 were included in a multicenter
retrospective-prospective cohort study. Patients admitted between March 1, 2020, and July 31, 2021, …
retrospective-prospective cohort study. Patients admitted between March 1, 2020, and July 31, 2021, …
[HTML][HTML] Ketamine-based sedation in critically ill COVID-19 patients with ARDS: Impact on hospital length of stay, oxygenation, and lactic acid normalization
…, BS Al-Dosari, AA Alenazi, S Alsohimi… - Saudi Pharmaceutical …, 2024 - Elsevier
… in mechanically ventilated critically ill patients with COVID-19 is insufficient and uncertain.
Therefore, the objective of this study is to evaluate the effectiveness and safety of ketamine …
Therefore, the objective of this study is to evaluate the effectiveness and safety of ketamine …
[HTML][HTML] Prescribing pattern of proton pump inhibitors among patients admitted to medical ward at King Abdulaziz University Hospital, Jeddah, Saudi Arabia: A …
BS Al-Dosari, BM Binafeef, SA Alsolami - Saudi Medical Journal, 2021 - ncbi.nlm.nih.gov
Objectives: To determine the prescription pattern of proton pump inhibitors (PPIs) at a tertiary
hospital in Saudi Arabia. Methods: This study was a retrospective cohort design using …
hospital in Saudi Arabia. Methods: This study was a retrospective cohort design using …
Adverse events associated with COVID-19 treatment and their possible relationship with patient characteristics: A narrative review
OY Al-Shargi, SM Alzaid, BS Al-Dosari… - Journal of Applied …, 2023 - japsonline.com
… Alshargi O, Alzaid S, Albahouth Z, Jaber A, Al-Dosari B. Clinical applications of
pharmacometabonomics in neurology: current status, future perspectives and challenges. Res J …
pharmacometabonomics in neurology: current status, future perspectives and challenges. Res J …
[HTML][HTML] Association between tocilizumab and emerging multidrug-resistant organisms in critically ill patients with COVID-19: A multicenter, retrospective cohort study
…, H Noureldeen, M Aboudeif, B Al Dosari… - BMC Infectious …, 2021 - Springer
Background Tocilizumab is an IgG1 class recombinant humanized monoclonal antibody
that directly inhibits the IL-6 receptor. Several randomized clinical trials have evaluated its …
that directly inhibits the IL-6 receptor. Several randomized clinical trials have evaluated its …
Clinical applications of pharmacometabonomics in neurology: Current status, future perspectives and challenges
…, ZI Albahouth, JA Ali, BS Al-Dosari - Research Journal of …, 2022 - indianjournals.com
Background Pharmacometabonomics is a new approach developed in the delivery of
personalized medicine to improve optimal drug efficacy and safety to patients. We summarized the …
personalized medicine to improve optimal drug efficacy and safety to patients. We summarized the …
Statins' safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study
…, G Albarrak, I Al Sulaihim, B Alanazi, BS Al-Dosari… - 2021 - researchsquare.com
… Security Hospitals Bodoor S. Al-Dosari King Abdulaziz University Hospital Ramesh
Vishwakarma European Organisation for Research and Treatment of Cancer Alawi S. Alsaeedi …
Vishwakarma European Organisation for Research and Treatment of Cancer Alawi S. Alsaeedi …
[HTML][HTML] Tocilizumab Association with Emerging Multi-drug Resistance Organisms and Mortality in critically ill patients with Coronavirus disease 2019 (COVID-19): A …
O Aljuhani, KA Sulaiman, A Alshabasy, K Eljaaly… - 2021 - europepmc.org
… These studies demonstrated conflicting results regarding tocilizumab’s efficacy and safety.
Our study aim is to determine the association between treatment with tocilizumab and …
Our study aim is to determine the association between treatment with tocilizumab and …
Statins' safety and impact on the clinical outcomes in COVID-19 critically ill patients: A Multicenter, Cohort Study (preprint)
…, G Albarrak, I Al Sulaihim, B Alanazi, B Al-Dosari… - 2021 - pesquisa.bvsalud.org
Background: The cardiovascular complications of Severe Coronavirus Disease 2019 (COVID-19)
may be attributed to the hyperinflammatory state leading to increased mortality in …
may be attributed to the hyperinflammatory state leading to increased mortality in …